Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.175 AUD | -5.41% | -7.89% | +52.17% |
May. 17 | PharmAust Appoints Nonexecutive Chair; Shares Up 3% | MT |
May. 17 | PharmAust Obtains Orphan Drug Designation for Monepantel; Shares Up 5% | MT |
Business Summary
Sales per Business
AUD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical-Epichem
76.6
%
| 4 | 81.8 % | 3 | 76.6 % | -17.15% |
Corporate & Research
23.4
%
| 1 | 18.2 % | 1 | 23.4 % | +13.86% |
Sales per region
AUD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Australia
95.2
%
| 2 | 56.8 % | 3 | 95.2 % | +54.75% |
United States
3.6
%
| 0 | 5.9 % | 0 | 3.6 % | -44.72% |
Others
0.7
%
| 0 | 3.1 % | 0 | 0.7 % | -80.48% |
Switzerland
0.6
%
| 1 | 34.1 % | 0 | 0.6 % | -98.34% |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 374,065,597 | 269,131,892 ( 71.95 %) | 0 | 71.95 % |
Company contact information
Sector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
+52.17% | 48.8M | |
+37.78% | 705B | |
+32.82% | 583B | |
-3.51% | 364B | |
+19.94% | 332B | |
+5.14% | 291B | |
+16.64% | 238B | |
-4.13% | 210B | |
+10.63% | 209B | |
+9.32% | 169B |
- Stock Market
- Equities
- PAA Stock
- Company PharmAust Limited